NF-Kappabeta Activation Inhibitor
    1.
    发明申请
    NF-Kappabeta Activation Inhibitor 审中-公开
    NF-κB激活抑制剂

    公开(公告)号:US20090326259A1

    公开(公告)日:2009-12-31

    申请号:US12308364

    申请日:2007-06-13

    IPC分类号: C07C69/76

    摘要: The object is to provide a highly safe NF-κB activation inhibitor at a low cost which can be used for prevention and treatment of diseases associated with the activation of NF-κB such as inflammation or type-2 diabetes. Specifically, the NF-κB activation inhibitor comprises a compound represented by the chemical structural formula depicted in the following Chemical Formula 1 [wherein R1 represents a hydroxy group; R2 represents a hydroxy group, a methoxy group or an alkoxy group; and R3 represents an ester comprising triterpene or a salt thereof] or a salt of the compound as active ingredient. A representative example of the compound is hydroxycinnamic acid derivative triterpene alcohol ester.

    摘要翻译: 目的是以低成本提供高度安全的NF-κB活化抑制剂,其可用于预防和治疗与NF-κB活化相关的疾病如炎症或2型糖尿病。 具体地说,NF-κB激活抑制剂包含由下列化学式1所示的化学结构式表示的化合物[其中R1表示羟基; R2表示羟基,甲氧基或烷氧基; R3表示包含三萜烯或其盐的酯]或该化合物的盐作为活性成分。 该化合物的代表性实例是羟基肉桂酸衍生物三萜醇酯。